GLP-1s, priced honestly.

Nouri is an independent editorial site. We do not prescribe, dispense, or sell medication; we compare licensed GLP-1 providers and their published prices, and may earn a commission. This archived page covers what to check in a GLP-1 price before you join a provider.

Nouri no longer offers its own GLP-1 program. Compare current options: cheapest GLP-1 prices, best compounded GLP-1 providers, or GLP-1 dose calculators.

Compounded GLP-1s are not FDA-approved. Safety info →

Nouri no longer offers its own GLP-1 program. Compare current options: cheapest GLP-1 prices, best compounded GLP-1 providers, or GLP-1 dose calculators.

Compounded semaglutide is not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Compounded medications are prepared based on a prescription from a licensed provider for a specific patient.

GLP-1 medications require a prescription after a medical evaluation by a licensed healthcare provider. Not all patients are eligible. Treatment decisions are made by licensed providers based on individual medical history.

Important Safety Information
What the research shows

The science is real.

15–20%

average body-weight reduction in clinical trials of the branded GLP-1 medications semaglutide and tirzepatide — achieved alongside a structured nutrition and movement plan.

Start Average trajectory in clinical studies · STEP 1 / SURMOUNT‑1, with diet & exercise ~14–17 mo
Questions

Honest pricing: common questions

Is compounded semaglutide legitimate?
Compounded semaglutide and tirzepatide are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing quality. They are prepared by a licensed U.S. 503A compounding pharmacy against an individual prescription from a U.S.-licensed physician, which is permitted under federal law. They are not equivalent to the FDA-approved brand-name drugs.
Will the price change on me?
It depends on the provider. Nouri no longer offers its own GLP-1 program. Ask any provider you compare whether its price changes with your dose, and read its billing terms before you join.
Are there any hidden fees?
Nouri no longer offers its own GLP-1 program. Before you join any provider, check whether its price includes the medication, clinician visits, dose changes, and shipping, and read its cancellation terms.
Can I use HSA or FSA funds, or pay over time?
Nouri does not sell medication or take payments. Whether HSA or FSA cards or buy-now-pay-later options are accepted depends on the provider, so check its checkout and ask your plan administrator about eligibility.
Do I need insurance?
Not necessarily. Many telehealth providers offer GLP-1 medications on a cash-pay basis without billing insurance. Nouri does not sell medication; compare current options in our cheapest GLP-1 cost comparison.
I stopped a GLP-1 because of the price. Can I restart?
Restarting is a medical decision, not a re-order: the prescriber at the provider you choose should review your prior dose and history and plan an appropriate restart. Not everyone qualifies. Nouri no longer offers its own GLP-1 program.
What are the side effects of compounded semaglutide?
The most common GLP-1 side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, and abdominal pain — and they usually ease as the dose is increased gradually. GLP-1s are not for everyone; people with a personal or family history of medullary thyroid carcinoma or MEN2 should not take them.
Can I cancel, and how do refunds work?
Nouri no longer offers its own GLP-1 program, so there is no Nouri plan to cancel and no Nouri refund term. Check each provider’s own cancellation and refund policy before you join.

Medically reviewed by Amber Patel, MD · Last reviewed June 30, 2026

References

  1. Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. doi:10.1056/NEJMoa2032183
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al; SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216. doi:10.1056/NEJMoa2206038